Literature DB >> 6780566

Assembly and processing of procollagen type III in chick embryo blood vessels.

L I Fessler, R Timpl, J H Fessler.   

Abstract

The processing of [3H]proline-labeled procollagen III in excised chick embryo blood vessels was found to differ significantly from that of procollagen I in the same tissue. While first the amino propeptides and then the carboxyl propeptides were fairly rapidly cleaved from procollagen I, only the carboxyl propeptides were split off procollagen III, leaving pN-collagen III. This intermediate, which is only slowly converted to collagen III by loss of amino propeptides, was characterized by its sedimentation properties, isolation of the amino propeptide, and reaction with purified antibodies that are specific against bovine amino propeptide III. It is interchain disulfide-linked, both through the amino propeptide and the carboxyl ends of the collagen chains. The conversion of procollagen III to pN-collagen III either in blood vessels, or after isolation by a carboxyl procollagen peptidase obtained from chick tendon fibroblast cultures, is inhibited by 50 mM arginine. Underhydroxylated procollagen III was isolated from blood vessels treated with alpha, alpha'-dipyridyl. Its amino propeptides reacted with the above antibodies but were not linked to each other. In contrast, its carboxyl propeptides were interchain disulfide-bridged, supporting previous suggestions that the carboxyl propeptides play a role in the assembly of procollagen trimer.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6780566

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Effect of dextran on synthesis, secretion and deposition of type III procollagen in cultured human fibroblasts.

Authors:  A Jukkola; J Risteli; L Risteli
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

2.  Purification of human procollagen type III N-proteinase from placenta and preparation of antiserum.

Authors:  R Halila; L Peltonen
Journal:  Biochem J       Date:  1986-10-01       Impact factor: 3.857

3.  Processing of types I and III procollagen in Ehlers-Danlos syndrome type VII.

Authors:  R Halila; B Steinmann; L Peltonen
Journal:  Am J Hum Genet       Date:  1986-08       Impact factor: 11.025

4.  Collagen fibril formation during embryogenesis.

Authors:  R Fleischmajer; B R Olsen; R Timpl; J S Perlish; O Lovelace
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

5.  Transpulmonary gradient of type III procollagen peptides: acute effects of cardio-pulmonary bypass.

Authors:  N K Harrison; G J Laurent; T W Evans
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

6.  The C-propeptide domain of procollagen can be replaced with a transmembrane domain without affecting trimer formation or collagen triple helix folding during biosynthesis.

Authors:  N J Bulleid; J A Dalley; J F Lees
Journal:  EMBO J       Date:  1997-11-17       Impact factor: 11.598

7.  Ultrastructural localization of type III procollagen in baboon liver.

Authors:  S Sato; M A Leo; C S Lieber
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

8.  The Caenorhabditis elegans rol-6 gene, which interacts with the sqt-1 collagen gene to determine organismal morphology, encodes a collagen.

Authors:  J M Kramer; R P French; E C Park; J J Johnson
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

9.  Ultrastructural identification of extension aminopropeptides of type I and III collagens in human skin.

Authors:  R Fleischmajer; R Timpl; L Tuderman; L Raisher; M Wiestner; J S Perlish; P N Graves
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

10.  Deposition of an intermediate form of procollagen type III (pN-collagen) into fibrils in the matrix of amniotic epithelial cells.

Authors:  K Hedman; K Alitalo; S Lehtinen; R Timpl; A Vaheri
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.